Does increased expression of glucocorticoid receptor support application of antagonists to this receptor for the treatment of castration resistant prostate cancer?

Lignende værker

• Androgen receptor targeted therapies in castration‐resistant prostate cancer: Bench to clinic
  af: Imamura, Yusuke, et al.
  Udgivet: (2016)
• Androgen Receptor Splice Variant 7 Drives the Growth of Castration Resistant Prostate Cancer without Being Involved in the Efficacy of Taxane Chemotherapy
  af: Shimizu, Yasuomi, et al.
  Udgivet: (2018)
• Crosstalk between the Androgen Receptor and β-Catenin in Castrate Resistant Prostate Cancer
  af: Wang, Gang, et al.
  Udgivet: (2008)
• Androgen Receptor Antagonists in Castration-Resistant Prostate Cancer
  af: Rathkopf, Dana, et al.
  Udgivet: (2013)
• Combination therapy with androgen receptor N‐terminal domain antagonist EPI‐7170 and enzalutamide yields synergistic activity in AR‐V7‐positive prostate cancer
  af: Hirayama, Yukiyoshi, et al.
  Udgivet: (2020)